Active 0 6 0 6 O
cardiac 7 14 7 14 B-chronic_disease
disease 15 22 15 22 I-chronic_disease
: 22 23 22 23 O
symptomatic 24 35 24 35 O
angina 36 42 36 42 B-chronic_disease
pectoris 43 51 43 51 I-chronic_disease
within 52 58 52 58 O
the 59 62 59 62 O
past 63 67 63 67 B-upper_bound
90 68 70 68 70 I-upper_bound
days 71 75 71 75 I-upper_bound
that 76 80 76 80 O
required 81 89 81 89 O
the 90 93 90 93 O
initiation 94 104 94 104 O
of 105 107 105 107 O
or 108 110 108 110 O
increase 111 119 111 119 O
in 120 122 120 122 O
anti 123 127 123 127 B-treatment
- 127 128 127 128 I-treatment
anginal 128 135 128 135 I-treatment
medication 136 146 136 146 I-treatment
or 147 149 147 149 O
other 150 155 150 155 O
intervention 156 168 156 168 O

Active 0 6 169 175 O
hepatitis 7 16 176 185 B-chronic_disease
B 17 18 186 187 I-chronic_disease
or 19 21 188 190 O
hepatitis 22 31 191 200 B-chronic_disease
C 32 33 201 202 I-chronic_disease
with 34 38 203 207 O
abnormal 39 47 208 216 O
liver 48 53 217 222 O
function 54 62 223 231 O
tests 63 68 232 237 O

Active 0 6 238 244 B-chronic_disease
infection 7 16 245 254 I-chronic_disease
or 17 19 255 257 O
chronic 20 27 258 265 B-chronic_disease
infection 28 37 266 275 I-chronic_disease
requiring 38 47 276 285 O
chronic 48 55 286 293 O
suppressive 56 67 294 305 B-treatment
antibiotics 68 79 306 317 I-treatment

Breast 0 6 318 324 B-cancer
cancer 7 13 325 331 I-cancer
must 14 18 332 336 O
be 19 21 337 339 O
determined 22 32 340 350 O
by 33 35 351 353 O
local 36 41 354 359 O
testing 42 49 360 367 O
to 50 52 368 370 O
be 53 55 371 373 O
human 56 61 374 379 O
epidermal 62 71 380 389 O
growth 72 78 390 396 O
factor 79 85 397 403 O
receptor 86 94 404 412 O
2 95 96 413 414 O
( 97 98 415 416 O
HER2)-positive 98 112 416 430 O
prior 113 118 431 436 O
to 119 121 437 439 O
study 122 127 440 445 O
entry 128 133 446 451 O
using 134 139 452 457 O
American 140 148 458 466 O
Society 149 156 467 474 O
of 157 159 475 477 O
Clinical 160 168 478 486 O
Oncology 169 177 487 495 O
( 178 179 496 497 O
ASCO 179 183 497 501 O
) 183 184 501 502 O
- 185 186 503 504 O
College 187 194 505 512 O
of 195 197 513 515 O
American 198 206 516 524 O
Pathologists 207 219 525 537 O
( 220 221 538 539 O
CAP 221 224 539 542 O
) 224 225 542 543 O
HER2 226 230 544 548 B-clinical_variable
test 231 235 549 553 I-clinical_variable
guidelines 236 246 554 564 O

Cardiac 0 7 565 572 B-chronic_disease
disease 8 15 573 580 I-chronic_disease
( 16 17 581 582 O
history 17 24 582 589 O
of 25 27 590 592 O
and/or 28 34 593 599 O
active 35 41 600 606 O
disease 42 49 607 614 O
) 49 50 614 615 O
that 51 55 616 620 O
would 56 61 621 626 O
preclude 62 70 627 635 O
the 71 74 636 639 O
use 75 78 640 643 O
of 79 81 644 646 O
any 82 85 647 650 O
of 86 88 651 653 O
the 89 92 654 657 O
drugs 93 98 658 663 O
included 99 107 664 672 O
in 108 110 673 675 O
the 111 114 676 679 O
treatment 115 124 680 689 B-treatment
regime 125 131 690 696 O

Chronic 0 7 697 704 O
daily 8 13 705 710 O
treatment 14 23 711 720 B-treatment
with 24 28 721 725 I-treatment
corticosteroids 29 44 726 741 I-treatment
with 45 49 742 746 O
a 50 51 747 748 O
dose 52 56 749 753 O
of 57 59 754 756 O
greater 60 67 757 764 O
than 68 72 765 769 O
or 73 75 770 772 O
equal 76 81 773 778 O
to 82 84 779 781 O
10 85 87 782 784 B-lower_bound
mg 88 90 785 787 I-lower_bound
/ 90 91 787 788 I-lower_bound
day 91 94 788 791 I-lower_bound
methylprednisolone 95 113 792 810 B-treatment
equivalent 114 124 811 821 O
( 125 126 822 823 O
excluding 126 135 823 832 O
inhaled 136 143 833 840 B-treatment
steroids 144 152 841 849 I-treatment
) 152 153 849 850 O

Conditions 0 10 851 861 O
that 11 15 862 866 O
would 16 21 867 872 O
prohibit 22 30 873 881 O
intermittent 31 43 882 894 O
administration 44 58 895 909 O
of 59 61 910 912 O
corticosteroids 62 77 913 928 B-treatment
for 78 81 929 932 O
T 82 83 933 934 O
- 83 84 934 935 O
DM1 84 87 935 938 O
premedication 88 101 939 952 O

HIV 0 3 953 956 B-chronic_disease
positive 4 12 957 965 O
patients 13 21 966 974 O
receiving 22 31 975 984 O
antivirals 32 42 985 995 B-treatment

History 0 7 996 1003 O
of 8 10 1004 1006 O
cardiac 11 18 1007 1014 B-chronic_disease
disease 19 26 1015 1022 I-chronic_disease
: 26 27 1022 1023 O
myocardial 28 38 1024 1034 B-chronic_disease
infarction 39 49 1035 1045 I-chronic_disease
documented 50 60 1046 1056 O
by 61 63 1057 1059 O
elevated 64 72 1060 1068 O
cardiac 73 80 1069 1076 O
enzymes 81 88 1077 1084 O
or 89 91 1085 1087 O
persistent 92 102 1088 1098 O
regional 103 111 1099 1107 O
wall 112 116 1108 1112 O
abnormalities 117 130 1113 1126 O
on 131 133 1127 1129 O
assessment 134 144 1130 1140 O
of 145 147 1141 1143 O
left 148 152 1144 1148 B-clinical_variable
ventricular 153 164 1149 1160 I-clinical_variable
( 165 166 1161 1162 I-clinical_variable
LV 166 168 1162 1164 I-clinical_variable
) 168 169 1164 1165 I-clinical_variable
function 170 178 1166 1174 I-clinical_variable

Lung 0 4 1175 1179 B-chronic_disease
disease 5 12 1180 1187 I-chronic_disease
resulting 13 22 1188 1197 O
in 23 25 1198 1200 O
dyspnea 26 33 1201 1208 B-chronic_disease
at 34 36 1209 1211 O
rest 37 41 1212 1216 O

Malabsorption 0 13 1217 1230 B-chronic_disease
syndrome 14 22 1231 1239 I-chronic_disease

Other 0 5 1240 1245 O
nonmalignant 6 18 1246 1258 B-chronic_disease
systemic 19 27 1259 1267 I-chronic_disease
disease 28 35 1268 1275 I-chronic_disease
that 36 40 1276 1280 O
would 41 46 1281 1286 O
preclude 47 55 1287 1295 O
the 56 59 1296 1299 O
patient 60 67 1300 1307 O
from 68 72 1308 1312 O
receiving 73 82 1313 1322 O
study 83 88 1323 1328 O
treatment 89 98 1329 1338 B-treatment
or 99 101 1339 1341 O
would 102 107 1342 1347 O
prevent 108 115 1348 1355 O
required 116 124 1356 1364 O
follow 125 131 1365 1371 O
up 132 134 1372 1374 O

Persistent 0 10 1375 1385 O
greater 11 18 1386 1393 O
than 19 23 1394 1398 O
or 24 26 1399 1401 O
equal 27 32 1402 1407 O
to 33 35 1408 1410 O
grade 36 41 1411 1416 B-lower_bound
2 42 43 1417 1418 I-lower_bound
diarrhea 44 52 1419 1427 B-chronic_disease
regardless 53 63 1428 1438 O
of 64 66 1439 1441 O
etiology 67 75 1442 1450 O

Pregnancy 0 9 1451 1460 B-pregnancy

Previous 0 8 1461 1469 B-treatment
therapy 9 16 1470 1477 I-treatment
with 17 21 1478 1482 I-treatment
T 22 23 1483 1484 I-treatment
- 23 24 1484 1485 I-treatment
DM1 24 27 1485 1488 I-treatment
or 28 30 1489 1491 O
any 31 34 1492 1495 O
HER2 35 39 1496 1500 B-treatment
tyrosine 40 48 1501 1509 I-treatment
kinase 49 55 1510 1516 I-treatment
inhibitor 56 65 1517 1526 I-treatment
( 66 67 1527 1528 I-treatment
TKI 67 70 1528 1531 I-treatment
) 70 71 1531 1532 I-treatment
including 72 81 1533 1542 O
neratinib 82 91 1543 1552 B-treatment
for 92 95 1553 1556 O
any 96 99 1557 1560 O
malignancy 100 110 1561 1571 B-cancer

Serum 0 5 1572 1577 B-clinical_variable
creatinine 6 16 1578 1588 I-clinical_variable
performed 17 26 1589 1598 O
within 27 33 1599 1605 O
4 34 35 1606 1607 B-upper_bound
weeks 36 41 1608 1613 I-upper_bound
prior 42 47 1614 1619 I-upper_bound
to 48 50 1620 1622 O
study 51 56 1623 1628 O
entry 57 62 1629 1634 O
must 63 67 1635 1639 O
be 68 70 1640 1642 O
less 71 75 1643 1647 O
than 76 80 1648 1652 O
or 81 83 1653 1655 O
equal 84 89 1656 1661 O
to 90 92 1662 1664 O
1.5 93 96 1665 1668 B-upper_bound
x 97 98 1669 1670 I-upper_bound
ULN 99 102 1671 1674 I-upper_bound
for 103 106 1675 1678 O
the 107 110 1679 1682 O
lab 111 114 1683 1686 O

Symptomatic 0 11 1687 1698 O
brain 12 17 1699 1704 B-cancer
metastases 18 28 1705 1715 I-cancer
or 29 31 1716 1718 O
brain 32 37 1719 1724 O
metastases 38 48 1725 1735 O
requiring 49 58 1736 1745 O
chronic 59 66 1746 1753 O
steroids 67 75 1754 1762 B-treatment
to 76 78 1763 1765 O
control 79 86 1766 1773 O
symptoms 87 95 1774 1782 O

The 0 3 1783 1786 O
ECOG 4 8 1787 1791 B-clinical_variable
performance 9 20 1792 1803 I-clinical_variable
status 21 27 1804 1810 I-clinical_variable
must 28 32 1811 1815 O
be 33 35 1816 1818 O
less 36 40 1819 1823 O
than 41 45 1824 1828 O
or 46 48 1829 1831 O
equal 49 54 1832 1837 O
to 55 57 1838 1840 O
2 58 59 1841 1842 B-upper_bound

Total 0 5 1843 1848 B-clinical_variable
bilirubin 6 15 1849 1858 I-clinical_variable
must 16 20 1859 1863 O
be 21 23 1864 1866 O
less 24 28 1867 1871 O
than 29 33 1872 1876 O
or 34 36 1877 1879 O
equal 37 42 1880 1885 O
to 43 45 1886 1888 O
1.5 46 49 1889 1892 B-upper_bound
x 50 51 1893 1894 I-upper_bound
upper 52 57 1895 1900 I-upper_bound
limit 58 63 1901 1906 I-upper_bound
of 64 66 1907 1909 I-upper_bound
normal 67 73 1910 1916 I-upper_bound
( 74 75 1917 1918 I-upper_bound
ULN 75 78 1918 1921 I-upper_bound
) 78 79 1921 1922 I-upper_bound

Uncontrolled 0 12 1923 1935 O
hypertension 13 25 1936 1948 B-chronic_disease
defined 26 33 1949 1956 O
as 34 36 1957 1959 O
a 37 38 1960 1961 O
systolic 39 47 1962 1970 B-clinical_variable
BP 48 50 1971 1973 I-clinical_variable
greater 51 58 1974 1981 O
than 59 63 1982 1986 O
150 64 67 1987 1990 B-lower_bound
mmHg 68 72 1991 1995 I-lower_bound
or 73 75 1996 1998 O
diastolic 76 85 1999 2008 B-clinical_variable
BP 86 88 2009 2011 I-clinical_variable
greater 89 96 2012 2019 O
than 97 101 2020 2024 O
90 102 104 2025 2027 B-lower_bound
mmHg 105 109 2028 2032 I-lower_bound
, 109 110 2032 2033 O
with 111 115 2034 2038 O
or 116 118 2039 2041 O
without 119 126 2042 2049 O
anti 127 131 2050 2054 B-treatment
- 131 132 2054 2055 I-treatment
hypertensive 132 144 2055 2067 I-treatment
medications 145 156 2068 2079 I-treatment

Use 0 3 2080 2083 O
of 4 6 2084 2086 O
any 7 10 2087 2090 O
investigational 11 26 2091 2106 B-treatment
agent 27 32 2107 2112 I-treatment
within 33 39 2113 2119 O
4 40 41 2120 2121 B-upper_bound
weeks 42 47 2122 2127 I-upper_bound
prior 48 53 2128 2133 I-upper_bound
to 54 56 2134 2136 O
study 57 62 2137 2142 O
entry 63 68 2143 2148 O

ability 0 7 2149 2156 O
to 8 10 2157 2159 O
swallow 11 18 2160 2167 O
oral 19 23 2168 2172 B-treatment
medication 24 34 2173 2183 I-treatment

absolute 0 8 2184 2192 O
neutrophil 9 19 2193 2203 I-clinical_variable
count 20 25 2204 2209 I-clinical_variable
( 26 27 2210 2211 I-clinical_variable
ANC 27 30 2211 2214 I-clinical_variable
) 30 31 2214 2215 I-clinical_variable
must 32 36 2216 2220 O
be 37 39 2221 2223 O
greater 40 47 2224 2231 O
than 48 52 2232 2236 O
or 53 55 2237 2239 O
equal 56 61 2240 2245 O
to 62 64 2246 2248 O
1000 65 69 2249 2253 B-lower_bound
/ 69 70 2253 2254 I-lower_bound
mm3 70 73 2254 2257 I-lower_bound

adequate 0 8 2258 2266 O
hepatic 9 16 2267 2274 O
function 17 25 2275 2283 O
performed 26 35 2284 2293 O
within 36 42 2294 2300 O
4 43 44 2301 2302 B-upper_bound
weeks 45 50 2303 2308 I-upper_bound
prior 51 56 2309 2314 I-upper_bound
to 57 59 2315 2317 O
study 60 65 2318 2323 O
entry 66 71 2324 2329 O

aspartate 0 9 2330 2339 B-clinical_variable
aminotransferase 10 26 2340 2356 I-clinical_variable
( 27 28 2357 2358 I-clinical_variable
AST 28 31 2358 2361 I-clinical_variable
) 31 32 2361 2362 I-clinical_variable
and 33 36 2363 2366 O
alanine 37 44 2367 2374 B-clinical_variable
aminotransferase 45 61 2375 2391 I-clinical_variable
( 62 63 2392 2393 I-clinical_variable
ALT 63 66 2393 2396 I-clinical_variable
) 66 67 2396 2397 I-clinical_variable
must 68 72 2398 2402 O
be 73 75 2403 2405 O
less 76 80 2406 2410 O
than 81 85 2411 2415 O
or 86 88 2416 2418 O
equal 89 94 2419 2424 O
to 95 97 2425 2427 O
1.5 98 101 2428 2431 B-upper_bound
x 102 103 2432 2433 I-upper_bound
ULN 104 107 2434 2437 I-upper_bound
for 108 111 2438 2441 O
the 112 115 2442 2445 O
lab 116 119 2446 2449 O
or 120 122 2450 2452 O
less 123 127 2453 2457 O
than 128 132 2458 2462 O
or 133 135 2463 2465 O
equal 136 141 2466 2471 O
to 142 144 2472 2474 O
5 145 146 2475 2476 O
x 147 148 2477 2478 O
ULN 149 152 2479 2482 O
if 153 155 2483 2485 O
liver 156 161 2486 2491 B-cancer
metastasis 162 172 2492 2502 I-cancer

blood 0 5 2503 2508 B-clinical_variable
counts 6 12 2509 2515 I-clinical_variable
performed 13 22 2516 2525 I-clinical_variable
within 23 29 2526 2532 O
4 30 31 2533 2534 B-upper_bound
weeks 32 37 2535 2540 I-upper_bound
prior 38 43 2541 2546 I-upper_bound
to 44 46 2547 2549 O
study 47 52 2550 2555 O

documentation 0 13 2556 2569 O
that 14 18 2570 2574 O
the 19 22 2575 2578 O
patient 23 30 2579 2586 O
has 31 34 2587 2590 O
evidence 35 43 2591 2599 O
of 44 46 2600 2602 O
measurable 47 57 2603 2613 O
metastatic 58 68 2614 2624 B-cancer
breast 69 75 2625 2631 I-cancer
cancer 76 82 2632 2638 I-cancer
that 83 87 2639 2643 O
is 88 90 2644 2646 O
accessible 91 101 2647 2657 O
to 102 104 2658 2660 O
biopsy 105 111 2661 2667 B-treatment
at 112 114 2668 2670 O
study 115 120 2671 2676 O
entry 121 126 2677 2682 O

had 0 3 2683 2686 O
anti 4 8 2687 2691 B-treatment
- 8 9 2691 2692 I-treatment
HER2 9 13 2692 2696 I-treatment
based 14 19 2697 2702 I-treatment
therapy 20 27 2703 2710 I-treatment
with 28 32 2711 2715 I-treatment
pertuzumab 33 43 2716 2726 I-treatment
and 44 47 2727 2730 O
trastuzumab 48 59 2731 2742 B-treatment
for 60 63 2743 2746 I-treatment
neoadjuvant 64 75 2747 2758 I-treatment
therapy 76 83 2759 2766 I-treatment
, 83 84 2766 2767 O
adjuvant 85 93 2768 2776 O
therapy 94 101 2777 2784 O
or 102 104 2785 2787 O
with 105 109 2788 2792 O
first 110 115 2793 2798 B-treatment
line 116 120 2799 2803 I-treatment
therapy 121 128 2804 2811 I-treatment
for 129 132 2812 2815 O
metastatic 133 143 2816 2826 B-cancer
disease 144 151 2827 2834 I-cancer
( 152 153 2835 2836 O
which 153 158 2836 2841 O
may 159 162 2842 2845 O
include 163 170 2846 2853 O
trastuzumab 171 182 2854 2865 O
and 183 186 2866 2869 O
pertuzumab 187 197 2870 2880 O
either 198 204 2881 2887 O
sequentially 205 217 2888 2900 O
or 218 220 2901 2903 O
in 221 223 2904 2906 O
combination 224 235 2907 2918 O
) 235 236 2918 2919 O

has 0 3 2920 2923 O
any 4 7 2924 2927 O
psychiatric 8 19 2928 2939 B-chronic_disease
or 20 22 2940 2942 O
addictive 23 32 2943 2952 B-chronic_disease
disorder 33 41 2953 2961 I-chronic_disease
or 42 44 2962 2964 O
other 45 50 2965 2970 O
condition 51 60 2971 2980 O

hemoglobin 0 10 2981 2991 B-clinical_variable
must 11 15 2992 2996 O
be 16 18 2997 2999 O
greater 19 26 3000 3007 O
than 27 31 3008 3012 O
or 32 34 3013 3015 O
equal 35 40 3016 3021 O
to 41 43 3022 3024 O
9 44 45 3025 3026 B-lower_bound
g 46 47 3027 3028 I-lower_bound
/ 47 48 3028 3029 I-lower_bound
dL 48 50 3029 3031 I-lower_bound

histologic 0 10 3032 3042 O
or 11 13 3043 3045 O
cytologic 14 23 3046 3055 O
confirmation 24 36 3056 3068 O
of 37 39 3069 3071 O
the 40 43 3072 3075 O
diagnosis 44 53 3076 3085 O
of 54 56 3086 3088 O
invasive 57 65 3089 3097 O
adenocarcinoma 66 80 3098 3112 B-cancer
of 81 83 3113 3115 I-cancer
the 84 87 3116 3119 I-cancer
breast 88 94 3120 3126 I-cancer

inflammatory 0 12 3127 3139 B-chronic_disease
bowel 13 18 3140 3145 I-chronic_disease
disease 19 26 3146 3153 I-chronic_disease

left 0 4 3154 3158 B-clinical_variable
ventricular 5 16 3159 3170 I-clinical_variable
ejection 17 25 3171 3179 I-clinical_variable
fraction 26 34 3180 3188 I-clinical_variable
( 35 36 3189 3190 I-clinical_variable
LVEF 36 40 3190 3194 I-clinical_variable
) 40 41 3194 3195 I-clinical_variable
assessment 42 52 3196 3206 O
by 53 55 3207 3209 O
2 56 57 3210 3211 B-treatment
- 57 58 3211 3212 I-treatment
D 58 59 3212 3213 I-treatment
echocardiogram 60 74 3214 3228 I-treatment
or 75 77 3229 3231 O
multi 78 83 3232 3237 B-treatment
- 83 84 3237 3238 I-treatment
gated 84 89 3238 3243 I-treatment
acquisition 90 101 3244 3255 I-treatment
( 102 103 3256 3257 I-treatment
MUGA 103 107 3257 3261 I-treatment
) 107 108 3261 3262 I-treatment
scan 109 113 3263 3267 I-treatment
performed 114 123 3268 3277 O
within 124 130 3278 3284 O
90 131 133 3285 3287 B-upper_bound
days 134 138 3288 3292 I-upper_bound
prior 139 144 3293 3298 I-upper_bound
to 145 147 3299 3301 O
study 148 153 3302 3307 O
entry 154 159 3308 3313 O
must 160 164 3314 3318 O
be 165 167 3319 3321 O
greater 168 175 3322 3329 O
than 176 180 3330 3334 O
or 181 183 3335 3337 O
equal 184 189 3338 3343 O
to 190 192 3344 3346 O
50 193 195 3347 3349 B-lower_bound
% 195 196 3349 3350 I-lower_bound
regardless 197 207 3351 3361 O
of 208 210 3362 3364 O
the 211 214 3365 3368 O
facility 215 223 3369 3377 O
's 223 225 3377 3379 O
lower 226 231 3380 3385 O
limit 232 237 3386 3391 O
of 238 240 3392 3394 O
normal 241 247 3395 3401 O
( 248 249 3402 3403 O
LLN 249 252 3403 3406 O
) 252 253 3406 3407 O

other 0 5 3408 3413 O
disease 6 13 3414 3421 O
or 14 16 3422 3424 O
condition 17 26 3425 3434 O
significantly 27 40 3435 3448 O
affecting 41 50 3449 3458 O
gastrointestinal 51 67 3459 3475 B-chronic_disease
function 68 76 3476 3484 I-chronic_disease

platelet 0 8 3485 3493 B-clinical_variable
count 9 14 3494 3499 I-clinical_variable
must 15 19 3500 3504 O
be 20 22 3505 3507 O
greater 23 30 3508 3515 O
than 31 35 3516 3520 O
or 36 38 3521 3523 O
equal 39 44 3524 3529 O
to 45 47 3530 3532 O
100,000 48 55 3533 3540 B-lower_bound
/ 55 56 3540 3541 I-lower_bound
mm3 56 59 3541 3544 I-lower_bound

reproductive 0 12 3545 3557 O
potential 13 22 3558 3567 O
must 23 27 3568 3572 O
agree 28 33 3573 3578 B-contraception_consent
to 34 36 3579 3581 I-contraception_consent
use 37 40 3582 3585 I-contraception_consent
an 41 43 3586 3588 I-contraception_consent
effective 44 53 3589 3598 I-contraception_consent
non 54 57 3599 3602 I-contraception_consent
- 57 58 3602 3603 I-contraception_consent
hormonal 58 66 3603 3611 I-contraception_consent
method 67 73 3612 3618 I-contraception_consent
of 74 76 3619 3621 I-contraception_consent
contraception 77 90 3622 3635 I-contraception_consent
during 91 97 3636 3642 O
therapy 98 105 3643 3650 B-treatment
, 105 106 3650 3651 O
and 107 110 3652 3655 O
for 111 114 3656 3659 O
at 115 117 3660 3662 O
least 118 123 3663 3668 O
7 124 125 3669 3670 B-lower_bound
months 126 132 3671 3677 I-lower_bound
after 133 138 3678 3683 O
the 139 142 3684 3687 O
last 143 147 3688 3692 O
dose 148 152 3693 3697 O
of 153 155 3698 3700 O
study 156 161 3701 3706 O
therapy 162 169 3707 3714 O

resection 0 9 3715 3724 B-treatment
of 10 12 3725 3727 I-treatment
the 13 16 3728 3731 I-treatment
stomach 17 24 3732 3739 I-treatment
or 25 27 3740 3742 I-treatment
small 28 33 3743 3748 I-treatment
bowel 34 39 3749 3754 I-treatment

ulcerative 0 10 3755 3765 B-chronic_disease
colitis 11 18 3766 3773 I-chronic_disease

